Publications (23) Javier Rodríguez García publications

2023

  1. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

2019

  1. Postprandial glycemic response in a non-diabetic adult population: The effect of nutrients is different between men and women

    Nutrition and Metabolism, Vol. 16, Núm. 1

  2. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

    EBioMedicine, Vol. 43, pp. 537-552

2017

  1. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

2016

  1. Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia

    Life Sciences, Vol. 144, pp. 162-169

2015

  1. High Incidence of Hypoglycemia in Stable Insulin-Treated Type 2 Diabetes Mellitus: Continuous Glucose Monitoring vs. Self-Monitored Blood Glucose. Observational Prospective Study

    Canadian Journal of Diabetes, Vol. 39, Núm. 5, pp. 428-433

  2. Utilidad de los marcadores de remodelado óseo en la detección de enfermedad mineral ósea en pacientes con fenilcetonuria

    Medicina Clinica, Vol. 144, Núm. 5, pp. 193-197

2013

  1. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2010

  1. Levels of leptin, insulin, IGF-I, IGFBP-3, IL-6 and IL-8 in sera of patients with muscular dystrophy and mitochondrial encephalomyopathy

    Journal of Pediatric Neurology, Vol. 8, Núm. 4, pp. 375-379

2007

  1. Evolution of Subclinical Hypothyroidism in Children Treated With Antiepileptic Drugs

    Pediatric Neurology, Vol. 37, Núm. 6, pp. 426-430

2006

  1. Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital

    Journal of Child Neurology, Vol. 21, Núm. 1, pp. 48-53

2005

  1. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 243, Núm. 12, pp. 1272-1276

2003

  1. Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

    Brain and Development, Vol. 25, Núm. 2, pp. 102-106

2002

  1. Presence of bovine leptin in edible commercial milk and infant formula

    Journal of Endocrinological Investigation, Vol. 25, Núm. 8, pp. 670-674

2001

  1. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis

    Journal of Child Neurology, Vol. 16, Núm. 9, pp. 704-706

2000

  1. Cerebrospinal fluid purine metabolite and neuron-specific enolase concentrations after febrile seizures

    Brain and Development, Vol. 22, Núm. 7, pp. 427-431

  2. Ghrelin-induced growth hormone secretion in humans

    European Journal of Endocrinology, Vol. 143, Núm. 6

1999

  1. Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

    Brain and Development, Vol. 21, Núm. 1, pp. 16-19

1998

  1. Aciduria 3 -hidroxi-3 -metilglutârica y sîndrome Reye-like récurrente

    Revista de Neurologia, Vol. 26, Núm. 154, pp. 911-914